Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Laboratory Corporation of America stock

Learn how to easily invest in Laboratory Corporation of America stock.

Laboratory Corporation of America is a diagnostics & research business based in the US. Laboratory Corporation of America shares (LH) are listed on the NYSE and all prices are listed in US Dollars. Laboratory Corporation of America employs 75,000 staff and has a trailing 12-month revenue of around $15.3 billion.

How to buy Laboratory Corporation of America stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – LH. It's that simple.

Best for beginners

Finder Award

eToro


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • Get $10 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Laboratory Corporation of America stock price (NYSE: LH)

Use our graph to track the performance of LH stocks over time.

Laboratory Corporation of America shares at a glance

Information last updated 2023-01-24.
Latest market close$253.70
52-week range$199.73 - $287.71
50-day moving average $239.20
200-day moving average $238.28
Wall St. target price$281.00
PE ratio 13.4102
Dividend yield $1.44 (1.12%)
Earnings per share (TTM) $18.94

Buy Laboratory Corporation of America stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Laboratory Corporation of America stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Laboratory Corporation of America price performance over time

Historical closes compared with the close of $253.7 from 2023-01-25

1 week (2023-01-19) 0.44%
1 month (2022-12-23) 9.52%
3 months (2022-10-26) 10.33%
6 months (2022-07-26) 2.75%
1 year (2022-01-26) -4.91%
2 years (2021-01-26) 14.29%
3 years (2020-01-24) 43.19%
5 years (2018-01-26) 43.81%

Is Laboratory Corporation of America stock undervalued or overvalued?

Valuing Laboratory Corporation of America stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Laboratory Corporation of America's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Laboratory Corporation of America's P/E ratio

Laboratory Corporation of America's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Laboratory Corporation of America shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Laboratory Corporation of America's PEG ratio

Laboratory Corporation of America's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0682. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Laboratory Corporation of America's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Laboratory Corporation of America's EBITDA

Laboratory Corporation of America's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.

The EBITDA is a measure of a Laboratory Corporation of America's overall financial performance and is widely used to measure a its profitability.

Laboratory Corporation of America financials

Revenue TTM $15.3 billion
Operating margin TTM 16.96%
Gross profit TTM $5.6 billion
Return on assets TTM 7.95%
Return on equity TTM 17.02%
Profit margin 11.51%
Book value $112.64
Market capitalisation $22.5 billion

TTM: trailing 12 months

Laboratory Corporation of America's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Laboratory Corporation of America.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Laboratory Corporation of America's total ESG risk score

Total ESG risk: 19.26

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Laboratory Corporation of America's overall score of 19.26 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Laboratory Corporation of America is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Laboratory Corporation of America's environmental score

Environmental score: 4.17/100

Laboratory Corporation of America's environmental score of 4.17 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Laboratory Corporation of America's social score

Social score: 11.07/100

Laboratory Corporation of America's social score of 11.07 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Laboratory Corporation of America's governance score

Governance score: 13.02/100

Laboratory Corporation of America's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Laboratory Corporation of America is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Laboratory Corporation of America's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Laboratory Corporation of America scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Laboratory Corporation of America has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Laboratory Corporation of America Holdings was last rated for ESG on: 2019-01-01.

Total ESG score 19.26
Total ESG percentile 14.56
Environmental score 4.17
Environmental score percentile 7
Social score 11.07
Social score percentile 7
Governance score 13.02
Governance score percentile 7
Level of controversy 2

Laboratory Corporation of America share dividends

13%

Dividend payout ratio: 12.79% of net profits

Recently Laboratory Corporation of America has paid out, on average, around 12.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.12% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Laboratory Corporation of America shareholders could enjoy a 1.12% return on their shares, in the form of dividend payments. In Laboratory Corporation of America's case, that would currently equate to about $1.44 per share.

While Laboratory Corporation of America's payout ratio might seem low, this can signify that Laboratory Corporation of America is investing more in its future growth.

Laboratory Corporation of America's most recent dividend payout was on 13 March 2023. The latest dividend was paid out to all shareholders who bought their shares by 22 February 2023 (the "ex-dividend date").

Have Laboratory Corporation of America's shares ever split?

Laboratory Corporation of America's shares were split on a 2:1 basis on 13 May 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Laboratory Corporation of America shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Laboratory Corporation of America shares which in turn could have impacted Laboratory Corporation of America's share price.

Laboratory Corporation of America share price volatility

Over the last 12 months, Laboratory Corporation of America's shares have ranged in value from as little as $199.7332 up to $287.7074. A popular way to gauge a stock's volatility is its "beta".

LH.US volatility(beta: 1.05)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Laboratory Corporation of America's is 1.0471. This would suggest that Laboratory Corporation of America's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Laboratory Corporation of America overview

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories.

Frequently asked questions

What percentage of Laboratory Corporation of America is owned by insiders or institutions?
Currently 0.266% of Laboratory Corporation of America shares are held by insiders and 94.565% by institutions.
How many people work for Laboratory Corporation of America?
Latest data suggests 75,000 work at Laboratory Corporation of America.
When does the fiscal year end for Laboratory Corporation of America?
Laboratory Corporation of America's fiscal year ends in December.
Where is Laboratory Corporation of America based?
Laboratory Corporation of America's address is: 358 South Main Street, Burlington, NC, United States, 27215
What is Laboratory Corporation of America's ISIN number?
Laboratory Corporation of America's international securities identification number is: US50540R4092
What is Laboratory Corporation of America's CUSIP number?
Laboratory Corporation of America's Committee on Uniform Securities Identification Procedures number is: 50540R102

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site